- Pressemitteilung BoxID 524597
Identifying infected cows and sheep faster
First commercial detection method for Schmallenberg virus approved
The Schmallenberg virus was first detected on a livestock farm in Germany in November 2011 and has since spread throughout the whole of Europe. According to a publication by the Friedrich-Loeffler-Institut, the German Federal Research Institute for Animal Health, over 1,700 livestock farms are affected in Germany alone. Cattle, sheep and goats in particular suffer from the virus, which is transmitted by insects. In ruminants, the acute infection leads to a high fever, diarrhoea and a strong decline in milk production. In the case of pregnant animals, the virus is transmitted to the foetus, resulting in deformities, stillbirth or miscarriage. So far, it has been classified as harmless to humans.
Kornwestheim-based AnDiaTec GmbH & Co. KG is an international laboratory working on innovative detection methods for pathogens in veterinary and human medi-cine. The team led by Dr. Johannes Kehle has succeeded in developing a complete, commercially available detection method for the Schmallenberg virus, which has now been approved by the Friedrich-Löffler-Institut under the German Ordinance on Working with Animal Pathogens (Tierseuchengesetz). Using the "BoVir® Schmallenberg Virus real time RT-PCR Kit", the Schmallenberg virus can be detected quickly and reliably in blood and tissue samples from cattle and small ruminants. "Once again, AnDiaTec has shown that it can develop targeted products and respond promptly to market needs," states Dr. Klaus Eichenberg, Managing Director of BioRegio STERN.
Founded in 2003, AnDiaTec GmbH & Co. KG develops and produces innovative in-vitro diagnostics for human and veterinary applications. The laboratory is accredited to DIN EN ISO/IEC 17025 and 15189 and has extensive expertise in analytics and diagnostics. Development geneticist Dr. Johannes Kehle is the company's Managing Director.
Über BioRegio STERN Management GmbH
For ten years, BioRegio STERN Management GmbH has been a skill-sharing network in the cities of Stuttgart, Tübingen, Esslingen, and Reutlingen and the Neckar-Alb and Stuttgart regions in the Baden-Württemberg area of Germany, providing a source of help and advice for founders of new businesses, entrepreneurs and researchers from the biotechnology sector. BioRegio STERN Management GmbH represents their interests in dealings with politicians, the media and associations. It offers business promotion and marketing services and provides advice on grant applications and corporate financing. Regenerative medicine, medical technology and the automation of biotechnology are key focal points. The Managing Director, Dr. Klaus Eichenberg, is a molecular and cell biologist and investment analyst.
Diese Pressemitteilungen könnten Sie auch interessieren
Analytik, Medizin, Luftfahrt, Militär, Industrie, Telekommunikation oder Industrie-Kommunikation - für jedes Gebiet gibt es eine ideale Großkernfaser mit Stufenindex-Profil...
Mitte 2012 hat der deutsche Medizinlaserentwickler StarMedTec GmbH einen Exklusivvertrag mit der in Mexiko City ansässigen Firma Dewimed S.A. als Vertriebspartner...
Fraunhofer FIT präsentiert auf dem European Lab Automation-Kongress 2013 am 6.-7. Juni 2013 in Hamburg eine Software für die Analyse der Teilung von lebenden Zellen....